Abstract
Obesity is among the main contributing factors in the etiology of essential hypertension (EHT). Leptin, the product of the ob gene, is expressed mainly in adipose tissue. We examined the relationship between two trace elements, zinc (Zn) and copper (Cu), and leptin in patients with EHT (n=35) and normotensive (NT) controls (n=50) because leptin as well as Zn and Cu were reported to be associated with the pathophysiology of EHT. Plasma leptin levels were determined with a commercial enzyme-linked immunosorbent assay (ELISA) kit. Atomic absorption spectrophotometry was utilized to determine plasma Zn and Cu levels. There was a negative correlation between leptin and Zn, and the Zn/Cu ratio (r=−0.359, p<0.05; r=0.361, p<0.05, respectively) in pooled subjects. When subjects were divided based on the presence or absence of hypertension, there was a negative correlation between leptin and Zn (r=−0.375, p<0.05) as well as leptin and Zn/Cu ratio (r=−0.398, p<0.05) in NT subjects. Similar trends were observed when leptin/BMI (body mass index) levels were utilized. There was no significant correlations between levels of Cu and leptin or leptin/BMI. In conclusion, in addition to high leptin levels, Zn and the Zn/Cu ratio were lower in patients with EHT compared to NT controls.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. A. Staessen, J. Wang, G. Bianchi, et al., Essential hypertension, Lancet 361, 1629–1641 (2003).
W. A. Hsueh and T. A. Buchanan, Obesity and hypertension, Endocrinol. Metab. Clin. North Am. 23, 405–427 (1994).
S. Klein, S. W. Coppack, V. Mohamed-Ali, et al., Adipose tissue leptin production and plasma leptin kinetics in humans, Diabetes 45, 984–987 (1996).
R. S. Ahima and J. S. Flier, Leptin, Annu. Rev. Physiol. 62, 413–437 (2000).
D. A. Sandoval and S. N. Davis, Leptin. Metabolic control and regulation, J. Diabetes Complic. 17, 108–113 (2003).
M. M. Veniant and C. P. LeBel, Leptin: from animals to humans, Curr. Pharm. Des. 9, 811–818 (2003).
P. M. Suter, R. Locher, E. Hasler, et al., Is there a role for the ob gene product leptin in essential hypertension? Am. J. Hypertens. 11, 1305–1311 (1998).
P. Saltman, Trace elements and blood pressure, Ann. Intern. Med. 98, 823–827 (1983).
G. Vivoli, M. Bergomi, R. Rovesti, et al., Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension, Biol. Trace Element Res. 49, 97–106 (1995).
D. V. Rayner and P. Trayhurn, Regulation of leptin production: sympathetic nervous system interactions, J. Mol. Med. 79, 8–20 (2001).
W. G. Haynes, W. I. Sivitz, D. A. Morgan, et al., Sympathetic and cardiorenal actions of leptin, Hypertension 30, 619–623 (1997).
J. E. Hall, D. A. Hildebrant, and J. Kuo, Obesity hypertension: role of leptin and sympathetic nervous system, Am. J. Hypertens. 14, 103–115 (2001).
H. Takizawa, N. Ura, S. Saitoh, et al., Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension, Clin. Exp. Hypertens. 23, 357–368 (2001).
W. H. Sheu, W. J. Lee, and Y. T. Chen, High plasma leptin concentrations in hypertensive men but not in hypertensive women, J. Hypertens. 17, 1289–1295 (1999).
F. Mallamaci, F. Cuzzola, G. Tripepi, et al., Gender-dependent differences in plasma leptin in essential hypertension, Am. J. Hypertens. 13, 914–920 (2000).
A. H. El-Gharbawy, J. M. Kotchen, C. E. Grim, et al., Gender-specific correlates of leptin with hypertension-related phenotypes in A frican Americans, Am. J. Hypertens. 15, 989–993 (2002).
H. Canatan, I. Bakan, M. Akbulut, et al., Comparative analysis of plasma leptin levels in both gender of patients with essential hypertension and healthy subjects, Endocr. Res. 30, 95–105 (2004).
S. Olusi, A. Al-Awadhi, C. Abiaka, et al., Serum copper levels and not zinc are positively associated with serum leptin concentrations in the healthy adult population, Biol Trace Element Res. 91, 137–144 (2003).
M. Tokdemir, S. A. Polat, Y. Acik, et al., Blood zinc and copper concentrations in criminal and non criminal schizophrenic men, Arch. Androl. 49, 365–368 (2003).
G. Cikim, H. Canatan, M. F. Gursu, et al., Levels of zinc and lipid peroxidation in acute coronary syndrome, Biol Trace Element Res. 96, 61–69 (2003).
J. Agata, A. Masuda, M. Takada, et al., High plasma immunoreactive leptin level in essential hypertension, Am. J. Hypertens. 10, 1171–1174 (1997).
J. P. Montani, V. Antic, Z. Yang, et al., Pathways from obesity to hypertension: from the perspective of a vicious triangle, Int. J. Obes. Related Metab. Disord. 26(Suppl. 2), S28-S38, (2002).
B. L. Vallee and D. S. Auld, Zinc coordination, function, and structure of zinc enzymes and other proteins, Biochemistry 29, 5647–5659 (1990).
D. L. Tallman and C. G. Taylor, Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in C57BL/6J mice, J. Nutr. Biochem. 14, 17–23 (2003).
M. D. Chen, Y. M. Song, et al., Zinc may be a mediator of leptin production in humans, Life Sci. 66, 2143–2149 (2000).
E. S. Ott and N. F. Shay, Zinc deficiency reduces leptin gene expression and leptin secretion in rat adipocytes, Exp. Biol. Med. (Maywood) 226, 841–846 (2001).
C. S. Mantzoros, A. S. Prasad, F. W. Beck, et al. Zinc may regulate serum leptin concentrations in humans, J. Am. Coll. Nutr. 17, 270–275 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Canatan, H., Bakan, I., Akbulut, M. et al. Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biol Trace Elem Res 100, 117–123 (2004). https://doi.org/10.1385/BTER:100:2:117
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:100:2:117